Addressing the Challenges of Cold Agglutinin Disease: From Diagnosis to Treatment

Yale Cancer Center
G

Yale ASH Updates on Classical Hematology: PROs of Sutimlimab Use in Cold Agglutinin Disease, Efgartigimod in ITP, Splenectomy in Immune Cytopenias

By Yale Cancer Center FEATURING George Goshua
By Yale Cancer Center FEATURING George Goshua
347 views
March 15, 2023
Comments 0
Login to view comments. Click here to Login
16:07

Current Management of CAD and the Role of Complement Activation

Shirley D'Sa

45 views
13:52

Diagnosis and Testing Considerations for Cold Agglutinin Disease

Julia Cunningham

171 views
23:57

The Role of Complement in Disease: Focus on PNH, aHUS, CAPS, and CAD

Ilene Weitz

151 views
13:41

CAD: The Basics and Development

Kelly Davidson

354 views
18:39

CAD: The Importance of Treatment Continuity

Sigbjørn Berentsen

68 views
20:56

Sutimlimab in Cold Agglutinin Disease

Kelly Davidson

166 views
10:29

2-Year Results From the CARDINAL Study: Sutimlimab for Complement C1…

Catherine Broome

67 views
22:22

Cold Agglutinin Disease: Pharmacologic Treatment and Clinical Monito…

Irina Murakhovskaya

222 views
07:59

CARDINAL Trial 2-Year Follow-Up: Long-Term Sutimlimab for Patients W…

Keck School of Medicine of USC

I. Weitz

158 views
07:27

Sutimlimab in Cold Agglutinin Disease: Safety From the Phase 3 Cardi…

Catherine Broome

239 views
34:15

Advances in Hemolytic Anemias: Enzymopathies, Membrane Defects, Auto…

Scripps Health

I. Weitz

544 views
32:32

Refractory Cold Agglutinin Disease Overview and Case Discussion

BMFcases

S. Berentsen, T. Bat

319 views